{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:34:14Z","timestamp":1792683254017,"version":"4.5.0"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Anticoagulant drugs are essential for managing thrombotic diseases but lead to increasing bleeding risk. The choice of suitable anticoagulant drugs requires an assessment of the patient\u2019s thrombotic risk factors and underlying ischemic pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study constructs a closed-loop framework integrating qualitative literature review and quantitative data analysis to evaluate bleeding risks in anticoagulant therapy. The qualitative review covers molecular mechanisms, risk factors, and nursing practices related to anticoagulant drugs. Quantitatively, we analyzed the bleeding events from the FDA Adverse Event Reporting System (FAERS) database (2004\u20132024), using disproportionality analysis with Reporting Odds Ratio, Proportional Reporting Ratio, Bayesian Confidence Propagation Neural Network, and Empirical Bayes Geometric Mean to identify significant bleeding signals. For each anticoagulant drug, the 10 strongest signals were extracted and anatomically profiled to construct a drug-specific hemorrhage atlas. Logistic regression analyses were applied to investigate the effects of age, sex, reporter, and comorbidities on the occurrence of anticoagulant drugs-associated bleeding. To address the critical issue of bleeding risk management in the clinic, we further discussed the multidisciplinary nursing across the anticoagulation therapy cycle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study revealed significant variations in bleeding risks among different anticoagulants. Anticoagulant-associated bleeding comprised 110\u00a0701 reports from FAERS database. Elderly patients (\u226565\u00a0years old) supplied 63.2% of cases; 32% of events emerged within 30\u00a0days of therapy initiation. Hospitalization was documented in 46.8% and death in 20.7%. Spinal subdural hemorrhage yielded the highest signal (ROR 144.79, 95% CI 28.09\u2013746.33), followed by adrenal, mesenteric, and intracranial hemorrhages among all anticoagulant drugs. Gastric\/lower gastrointestinal bleeding appeared in the top-10 list of every oral anticoagulant, while retroperitoneal bleeding was a shared high-signal event among heparins and parenteral direct thrombin inhibitors. Betrixaban exhibited extreme RORs for traumatic (ROR 18\u00a0059.67, 95% Cl: 8829.21\u201336\u00a0940.05) and intracranial (ROR 643.97, 95% Cl: 249.82\u20131660) bleeding. Each drug also exhibited distinct bleeding characteristics and differences in organ system distribution. Multivariable logistic regression across four hierarchical models identified agents with distinct, model-independent bleeding risk profiles relative to warfarin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This large-scale pharmacovigilance study provides the most comprehensive, publicly available atlas of anticoagulant-related bleeding signals. The pronounced inter-drug heterogeneity and persistent long-term risk mandate individualized choice of agent and prolonged monitoring to ultimately improve the safety\u2013efficacy balance of antithrombotic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004467","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T15:00:09Z","timestamp":1765983609000},"page":"7007-7026","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Anticoagulant-associated bleeding: real-world data-driven pharmacovigilance and insights for bleeding management"],"prefix":"10.1097","volume":"112","author":[{"given":"Xia","family":"Hong","sequence":"first","affiliation":[{"name":"Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wei","sequence":"additional","affiliation":[{"name":"Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Lian","family":"Wang","sequence":"additional","affiliation":[{"name":"Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-0156","authenticated-orcid":false,"given":"Liu-Cheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Li","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital, Quzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,16]]},"reference":[{"key":"R1-20260417","doi-asserted-by":"crossref","first-page":"10760296221132551","DOI":"10.1177\/10760296221132551","article-title":"Prescribing trends of oral anticoagulants from 2010 to 2020 in Shanghai, China: a retrospective study","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"R2-20260417","first-page":"393\u201397","article-title":"Safety and efficacy of newer oral anticoagulants versus Vitamin K antagonists in the management of cerebral venous thrombosis: a single-center ambispective study from South India","volume":"27","author":"Ramesh","year":"2024","journal-title":"Ann Indian Acad Neurol"},{"key":"R3-20260417","doi-asserted-by":"crossref","first-page":"555\u201368","DOI":"10.1007\/s10557-020-06981-3","article-title":"Anticoagulants for stroke prevention in atrial fibrillation in elderly patients","volume":"34","author":"Sch\u00e4fer","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"R4-20260417","doi-asserted-by":"crossref","first-page":"1815\u201316","DOI":"10.1056\/NEJMe2403726","article-title":"Reversing oral anticoagulation in intracerebral hemorrhage","volume":"390","author":"Smith","year":"2024","journal-title":"N Engl J Med"},{"key":"R5-20260417","doi-asserted-by":"crossref","first-page":"2093\u2013104","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"R6-20260417","doi-asserted-by":"crossref","first-page":"1231\u201342","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace"},{"key":"R7-20260417","first-page":"184\u2013200","article-title":"Does one dose really fit all? On the monitoring of direct oral anticoagulants: a review of the literature","volume":"40","author":"Moner-Banet","year":"2020","journal-title":"Hamostaseologie"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"519\u201324","DOI":"10.1177\/1076029616686421","article-title":"The utilization of antithrombotic therapy in older patients in aged care facilities with atrial fibrillation","volume":"24","author":"Frain","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"3910\u201322","DOI":"10.1097\/JS9.0000000000001307","article-title":"Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient, and postdischarge prophylaxis: a meta-analysis of randomized controlled trials","volume":"110","author":"Meng","year":"2024","journal-title":"Int J Surg"},{"key":"R10-20260417","doi-asserted-by":"crossref","first-page":"3648\u201355","DOI":"10.1097\/JS9.0000000000000656","article-title":"The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials","volume":"109","author":"Meng","year":"2023","journal-title":"Int J Surg"},{"key":"R11-20260417","doi-asserted-by":"crossref","first-page":"e000080","DOI":"10.1136\/openhrt-2014-000080","article-title":"Comparative analysis and meta-analysis of major clinical trials with oral factor Xa inhibitors versus warfarin in atrial fibrillation","volume":"1","author":"Nunes","year":"2014","journal-title":"Open Heart"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"f20","DOI":"10.1093\/ehjcvp\/pvz073","article-title":"Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440\u2009281 patients","volume":"7","author":"Silverio","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"321\u201328","DOI":"10.1002\/aorn.14019","article-title":"Guidelines in practice: prevention of venous thromboembolism","volume":"118","author":"Speth","year":"2023","journal-title":"Aorn J"},{"key":"R14-20260417","doi-asserted-by":"crossref","first-page":"119\u201331","DOI":"10.1097\/CNQ.0000000000000395","article-title":"Perioperative anticoagulation management","volume":"45","author":"Briete","year":"2022","journal-title":"Crit Care Nurs Q"},{"key":"R15-20260417","doi-asserted-by":"crossref","first-page":"986\u201392","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"R16-20260417","first-page":"100082","article-title":"Transparency in the reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.3390\/cells11203214","article-title":"Anticoagulants: a short history, their mechanism of action, pharmacology, and indications","volume":"11","author":"Heestermans","year":"2022","journal-title":"Cells"},{"key":"R18-20260417","doi-asserted-by":"crossref","first-page":"1767\u201376","DOI":"10.1016\/S0140-6736(20)32439-9","article-title":"Direct oral anticoagulants: evidence and unresolved issues","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"R19-20260417","doi-asserted-by":"crossref","first-page":"1538\u201357","DOI":"10.1016\/j.jacc.2023.07.025","article-title":"Antithrombotic therapy for primary and secondary prevention of ischemic stroke: JACC state-of-the-art review","volume":"82","author":"Greco","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R20-20260417","doi-asserted-by":"crossref","first-page":"1465\u201375","DOI":"10.1182\/blood.2023020722","article-title":"Targeting factor XI and factor XIa to prevent thrombosis","volume":"143","author":"Gailani","year":"2024","journal-title":"Blood"},{"key":"R21-20260417","first-page":"717\u201328","article-title":"Treatment of venous thromboembolism","volume":"311","author":"Wells","year":"2014","journal-title":"Jama"},{"key":"R22-20260417","doi-asserted-by":"crossref","first-page":"551\u201375","DOI":"10.1146\/annurev-pharmtox-032823-122811","article-title":"Oral anticoagulants beyond warfarin","volume":"64","author":"Olie","year":"2024","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R23-20260417","doi-asserted-by":"crossref","first-page":"2074\u201387","DOI":"10.1016\/j.clinthera.2021.09.021","article-title":"Real-world anticoagulant use and incidence of venous thromboembolism and major bleeding in children","volume":"43","author":"Hardin","year":"2021","journal-title":"Clin Ther"},{"key":"R24-20260417","doi-asserted-by":"crossref","first-page":"425\u201335","DOI":"10.1182\/blood-2018-06-820746","article-title":"Treatment of bleeding complications in patients on anticoagulant therapy","volume":"133","author":"Piran","year":"2019","journal-title":"Blood"},{"key":"R25-20260417","doi-asserted-by":"crossref","first-page":"833\u201341","DOI":"10.1007\/s12975-022-01097-2","article-title":"Associations between drug treatments and the risk of aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"14","author":"Shimizu","year":"2023","journal-title":"Transl Stroke Res"},{"key":"R26-20260417","first-page":"967\u201380","article-title":"Drug-drug interactions with direct oral anticoagulants","volume":"59","author":"Foerster","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"R27-20260417","doi-asserted-by":"crossref","first-page":"1420\u201329","DOI":"10.7326\/M21-1094","article-title":"Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann Intern Med"},{"key":"R28-20260417","doi-asserted-by":"crossref","first-page":"4051\u2013100","DOI":"10.1111\/bcp.14833","article-title":"Drug-drug interactions with warfarin: a systematic review and meta-analysis","volume":"87","author":"Wang","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R29-20260417","doi-asserted-by":"crossref","first-page":"85\u201393","DOI":"10.1016\/S2468-1253(16)30162-5","article-title":"Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis","volume":"2","author":"Burr","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R30-20260417","doi-asserted-by":"crossref","first-page":"444\u201353","DOI":"10.1093\/ehjcvp\/pvae042","article-title":"Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis","volume":"10","author":"Haller","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"R31-20260417","doi-asserted-by":"crossref","first-page":"132\u201350","DOI":"10.1016\/j.amjcard.2023.07.141","article-title":"An evidence-based approach to anticoagulation therapy comparing direct oral anticoagulants and Vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: a systematic review, meta-analysis, and network meta-analysis","volume":"206","author":"Suppah","year":"2023","journal-title":"Am J Cardiol"},{"key":"R32-20260417","doi-asserted-by":"crossref","first-page":"98\u2013104","DOI":"10.1080\/00016357.2022.2085324","article-title":"Risk of bleeding with dental implant surgery in patients on anticoagulant or antiplatelet drugs: a systematic review and meta-analysis","volume":"81","author":"Zou","year":"2023","journal-title":"Acta Odontol Scand"},{"key":"R33-20260417","doi-asserted-by":"crossref","first-page":"290\u201396","DOI":"10.1097\/MAT.0000000000001230","article-title":"Thrombosis and bleeding in Extracorporeal Membrane Oxygenation (ECMO) without anticoagulation: a systematic review","volume":"67","author":"Olson","year":"2021","journal-title":"Asaio J"},{"key":"R34-20260417","doi-asserted-by":"crossref","first-page":"1776\u201386","DOI":"10.1161\/STROKEAHA.124.047310","article-title":"Anticoagulation versus antiplatelets in spontaneous cervical artery dissection: a systematic review and meta-analysis","volume":"55","author":"Yaghi","year":"2024","journal-title":"Stroke"},{"key":"R35-20260417","doi-asserted-by":"crossref","first-page":"1509\u201318","DOI":"10.1111\/jcpt.13442","article-title":"The effects of anticoagulant therapy re-initiation after gastrointestinal bleeding: a systematic review and meta-analysis","volume":"46","author":"Bingzheng","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"R36-20260417","first-page":"Cd010956","article-title":"Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis","volume":"4","author":"Wang","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R37-20260417","first-page":"3014\u201324","article-title":"Direct oral anticoagulants versus Vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis","volume":"53","author":"Yaghi","year":"2022","journal-title":"Stroke"},{"key":"R38-20260417","doi-asserted-by":"crossref","first-page":"16\u201330","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs Vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R39-20260417","doi-asserted-by":"crossref","first-page":"3063\u201371","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"R40-20260417","doi-asserted-by":"crossref","first-page":"e070022","DOI":"10.1136\/bmj-2022-070022","article-title":"Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis","volume":"378","author":"Eck","year":"2022","journal-title":"Bmj"},{"key":"R41-20260417","doi-asserted-by":"crossref","first-page":"427\u201338","DOI":"10.1007\/s12272-021-01325-7","article-title":"Anti-thrombotic activity of phenolic acids obtained from Salvia miltiorrhiza f. alba in TNF-\u03b1-stimulated endothelial cells via the NF-\u03baB\/JNK\/p38 MAPK signaling pathway","volume":"44","author":"Zheng","year":"2021","journal-title":"Arch Pharm Res"},{"key":"R42-20260417","first-page":"2861\u201388","article-title":"Guidelines for prevention and treatment of thrombotic diseases in China","volume":"98","year":"2018","journal-title":"Nat Med J China"},{"key":"R43-20260417","doi-asserted-by":"crossref","first-page":"102354","DOI":"10.1016\/j.rpth.2024.102354","article-title":"Drug-related problems associated with direct oral anticoagulants: an observational cross-sectional study of medical record review by pharmacists in a large teaching hospital","volume":"8","author":"Chow","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"R44-20260417","doi-asserted-by":"crossref","first-page":"2269\u201378","DOI":"10.1182\/blood-2019-01-846048","article-title":"How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism","volume":"133","author":"Chan","year":"2019","journal-title":"Blood"},{"key":"R45-20260417","doi-asserted-by":"crossref","first-page":"131\u201338","DOI":"10.1097\/HPC.0000000000000205","article-title":"Bleeding events in patients 75 years of age and older under long-term anticoagulant therapy: a real-life study","volume":"19","author":"Conti","year":"2020","journal-title":"Crit Pathw Cardiol"},{"key":"R46-20260417","doi-asserted-by":"crossref","first-page":"5\u201315","DOI":"10.1177\/1076029613492010","article-title":"Oral anticoagulation therapy for elderly patients with atrial fibrillation: utility of bleeding risk covariates to better understand and moderate risks","volume":"20","author":"Forman","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"R47-20260417","doi-asserted-by":"crossref","first-page":"2987\u20133001","DOI":"10.1016\/j.jacc.2021.04.061","article-title":"Meta-analysis of reversal agents for severe bleeding associated with direct oral anticoagulants","volume":"77","author":"G\u00f3mez-Outes","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R48-20260417","doi-asserted-by":"crossref","first-page":"1515\u201324","DOI":"10.7326\/M22-0511","article-title":"Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population-based cohort study","volume":"175","author":"Lau","year":"2022","journal-title":"Ann Intern Med"},{"key":"R49-20260417","first-page":"e59208","article-title":"Non-traumatic spinal subdural hemorrhage associated with rivaroxaban use","volume":"16","author":"Navata","year":"2024","journal-title":"Cureus"},{"key":"R50-20260417","doi-asserted-by":"crossref","first-page":"77\u201385","DOI":"10.3904\/kjim.2023.098","article-title":"Risk factors for anticoagulant-associated gastrointestinal hemorrhage: a systematic review and meta-analysis","volume":"39","author":"Ma","year":"2024","journal-title":"Korean J Intern Med"},{"key":"R51-20260417","first-page":"45\u201350","article-title":"A nurse\u2019s guide to direct oral anticoagulants","volume":"36","author":"Gee","year":"2021","journal-title":"Nurs Stand"},{"key":"R52-20260417","first-page":"277\u201379","article-title":"Nursing of a patient with thrombotic thrombocytopenic purpura after radiofrequency ablation of liver cancer","volume":"2","author":"Lu","year":"2021","journal-title":"Chin J Emerg Crit Care Nurs"},{"key":"R53-20260417","first-page":"51\u201354","article-title":"Emergency nursing of thrombus detachment in the lower limbs in a patient with acute pulmonary embolism","volume":"5","author":"Tong","year":"2024","journal-title":"Chin J Emerg Crit Care Nurs"},{"key":"R54-20260417","first-page":"33\u201337","article-title":"Evidence-based practice in the use of subcutaneous anticoagulants","volume":"50","author":"Zhu","year":"2015","journal-title":"Chin J Nurs"},{"key":"R55-20260417","doi-asserted-by":"crossref","first-page":"2\u20137","DOI":"10.1097\/CNQ.0000000000000381","article-title":"Heparin-induced thrombocytopenia: a management review for nurses","volume":"45","author":"Smith","year":"2022","journal-title":"Crit Care Nurs Q"},{"key":"R56-20260417","first-page":"288\u201390,413","article-title":"Application value of nurse-led cluster anticoagulation management in patients with atrial fibrillation treated with warfarin anticoagulation","volume":"46","author":"Du","year":"2024","journal-title":"Sichuan J Physiol Sci"},{"key":"R57-20260417","first-page":"27\u201329","article-title":"Analysis of the impact of health education on the use of anticoagulant drugs in patients","volume":"7","author":"Yang","year":"2023","journal-title":"Int J Clin Res"},{"key":"R58-20260417","first-page":"709\u201316","article-title":"Expert consensus on nursing standards for subcutaneous injection of anticoagulant agents","volume":"28","author":"Alliance","year":"2019","journal-title":"J Intervent Radiol"},{"key":"R59-20260417","first-page":"526\u201330","article-title":"Effects of health education of integrated medical and nursing in follow-up management of atrialfibrillation patients with radiofrequency ablation","volume":"28","author":"Li","year":"2022","journal-title":"Chin J Mod Nurs"},{"key":"R60-20260417","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0049-3848(15)50441-6","article-title":"Assisted reproductive technologies and thrombosis","volume":"135 Suppl 1","author":"Grandone","year":"2015","journal-title":"Thromb Res"},{"key":"R61-20260417","doi-asserted-by":"crossref","first-page":"1414\u201323","DOI":"10.1007\/s43032-021-00678-0","article-title":"Low Molecular Weight Heparins (LMWH) and implications along pregnancy: a focus on the placenta","volume":"29","author":"Zullino","year":"2022","journal-title":"Reprod Sci"},{"key":"R62-20260417","first-page":"319\u201331","article-title":"Contemporary management of major haemorrhage in critical care","volume":"50","author":"Maier","year":"2024","journal-title":"Intensive Care Med"},{"key":"R63-20260417","first-page":"72\u201373","article-title":"Application and nursing of low molecular weight heparin anticoagulation therapy in freeze-thaw embryo transfer cycle","volume":"11","author":"Wang","year":"2017","journal-title":"Chinese J Mod Drug App"},{"key":"R64-20260417","doi-asserted-by":"crossref","first-page":"50\u201363","DOI":"10.7748\/ns.2018.e11060","article-title":"Principles and nursing management of anticoagulation","volume":"32","author":"Gee","year":"2018","journal-title":"Nurs Stand"},{"key":"R65-20260417","doi-asserted-by":"crossref","first-page":"1133662","DOI":"10.3389\/fcvm.2023.1133662","article-title":"Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature","volume":"10","author":"Li","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R66-20260417","doi-asserted-by":"crossref","first-page":"1512784","DOI":"10.3389\/fcvm.2025.1512784","article-title":"Case report: practice of whole-course pharmaceutical care: a case in hypertrophic cardiomyopathy and a review of the pharmacist\u2019s role","volume":"12","author":"Li","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"R67-20260417","doi-asserted-by":"crossref","first-page":"407\u201318","DOI":"10.1007\/s40256-023-00582-9","article-title":"Management of gastrointestinal bleeding and resumption of oral anticoagulant therapy in patients with atrial fibrillation: a multidisciplinary discussion","volume":"23","author":"Martin","year":"2023","journal-title":"Am J Cardiovasc Drugs"},{"key":"R68-20260417","doi-asserted-by":"crossref","first-page":"1055\u201370","DOI":"10.1007\/s40265-024-02049-w","article-title":"Therapeutic potential of FXI inhibitors: hype or hope?","volume":"84","author":"Galli","year":"2024","journal-title":"Drugs"},{"key":"R69-20260417","doi-asserted-by":"crossref","first-page":"117034","DOI":"10.1016\/j.carbpol.2020.117034","article-title":"Low-molecular-weight fucosylated glycosaminoglycan and its oligosaccharides from sea cucumber as novel anticoagulants: a review","volume":"251","author":"Li","year":"2021","journal-title":"Carbohydr Polym"},{"key":"R70-20260417","doi-asserted-by":"crossref","first-page":"771\u201379","DOI":"10.1016\/j.jacc.2022.11.057","article-title":"Clinical evaluation of factor XIa inhibitor drugs: JACC review topic of the week","volume":"81","author":"Harrington","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R71-20260417","doi-asserted-by":"crossref","first-page":"245\u201358","DOI":"10.1093\/ehjcvp\/pvae002","article-title":"Pharmacological and clinical appraisal of factor XI inhibitor drugs","volume":"10","author":"Occhipinti","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"R72-20260417","doi-asserted-by":"crossref","first-page":"52\u201371","DOI":"10.1111\/apt.17297","article-title":"Review article: the safety of anticoagulants and antiplatelet agents in patients with cirrhosis","volume":"57","author":"Ma","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"R73-20260417","doi-asserted-by":"crossref","first-page":"889\u201397","DOI":"10.2217\/pgs-2020-0046","article-title":"CYP2C19 genotype-guided antiplatelet therapy: promises and pitfalls","volume":"21","author":"Ellithi","year":"2020","journal-title":"Pharmacogenomics"},{"key":"R74-20260417","doi-asserted-by":"crossref","first-page":"406\u201312","DOI":"10.1002\/cpdd.1047","article-title":"Assessment of pharmacokinetic interaction between gefapixant (MK-7264), a P2X3 receptor antagonist, and the OATP1B1 drug transporter substrate pitavastatin","volume":"11","author":"McCrea","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"key":"R75-20260417","doi-asserted-by":"crossref","first-page":"331\u201338","DOI":"10.1161\/ATVBAHA.118.312130","article-title":"Intrinsic pathway of coagulation and thrombosis","volume":"39","author":"Grover","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R76-20260417","doi-asserted-by":"crossref","first-page":"193\u2013200","DOI":"10.1002\/jbm.a.36803","article-title":"Synthesis and evaluation of a novel nanoparticle carrying urokinase used in targeted thrombolysis","volume":"108","author":"Zhong","year":"2020","journal-title":"J Biomed Mater Res A"},{"key":"R77-20260417","doi-asserted-by":"crossref","first-page":"100079","DOI":"10.1016\/j.ijnsa.2022.100079","article-title":"Nurse-pharmacist collaborations for promoting medication safety among community-dwelling adults: a scoping review","volume":"4","author":"Ravi","year":"2022","journal-title":"Int J Nurs Stud Adv"},{"key":"R78-20260417","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/jehp.jehp_1240_21","article-title":"Assessment of knowledge and practice of cardiovascular nurses regarding warfarin","volume":"11","author":"Ehsani","year":"2022","journal-title":"J Educ Health Promot"},{"key":"R79-20260417","doi-asserted-by":"crossref","first-page":"825\u201332","DOI":"10.1111\/nuf.12770","article-title":"Nurses\u2019 knowledge of anticoagulation therapy for atrial fibrillation patients: effectiveness of an educational course","volume":"57","author":"Omoush","year":"2022","journal-title":"Nurs Forum"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:04:28Z","timestamp":1776423868000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,16]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004467","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,16]]},"assertion":[{"value":"2025-07-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}